Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPatterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada
Canadian Journal of Cardiology, 05/04/07
Kundhal, KK, et al. – Patients with PAD represent a high-risk group in which more than 75% have established coronary or cerebrovascular disease, or multiple cardiovascular risk factors. Although the use of antiplatelet agents is common, the use of statins, ACEIs and beta-blockers may be improved
Related Articles
Too Big to be Shared
Health Management Technology, 11/09/09
Relevance Score: 66%
Anaesthetic implications of congenital heart disease for children undergoing non-cardiac surgery
Anaesthesia & intensive care medicine, 10/08/09
Relevance Score: 66%
Acute Postoperative Pain Management By Surgical Team In A Tertiary Care Hospital: Patients Satisfaction
Middle East Journal of Anesthesiology, 10/06/09
Relevance Score: 66%
Intrathecal infusions for intractable cancer pain: A qualitative study of the impact on a case series of patients and caregivers
Pain Research and Management, 10/28/09
Relevance Score: 65%
Implementing a comprehensive, 24-hour emergency department pharmacy program
American Journal of Health-System Pharmacy, 10/26/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury
Atherosclerosis, 12/04/09
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD: a systematic review and meta-analysis
European Respiratory Journal , 12/03/09
The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model
American Journal of Cardiovascular Drugs, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor